Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000008

Chief Scientific Officer sold 2,334 shares at $7.99 ($18,649)

  • Chief Scientific Officer acquired 5,207 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hansen Gwenn · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-30 Exercise or conversion : show line 1 in the form +3,207 36,736 D
2024-01-30 Exercise or conversion : show line 2 in the form +2,000 38,736 D
2024-01-30 Sale : show line 3 in the form −2,334 $7.99 $18,649 36,402 D
Open-market sales · 2,334 sh · avg $7.99 · $18,649

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-01-30 Exercise or conversion : show line 4 in the form Restricted Stock Units −3,207 25,654 D
2024-01-30 Exercise or conversion : show line 5 in the form Restricted Stock Units −2,000 18,000 D
Loading xslF345X05/wk-form4_1706658767.xml…